High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy

Immunology Letters

Volumn 187, Issue , 2017, Pages 27-34

  Urbanova, Linda ^a,b   Hradilova, Nada ^a,b   Moserova, Irena ^a,b   Vosahlikova, Sarka ^a   Sadilkova, Lenka ^a   Hensler, Michal ^a   Spisek, Radek ^a,b   Adkins, Irena ^a,b  

^a Sotio   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

CD8+ T cells; Clinical trial; Dendritic cells; High hydrostatic pressure tumor associated antigens; Lung cancer immunotherapy

Indexed keywords

DENDRITIC CELL VACCINE; MESSENGER RNA; TUMOR ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HIGH HYDROSTATIC PRESSURE; HUMAN; HUMAN CELL; HYDROSTATIC PRESSURE; IMMUNOGENICITY; LUNG CANCER CELL LINE; MALE; OVARIAN CANCER CELL LINE; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; PROTEIN DEGRADATION; A-549 CELL LINE; DENDRITIC CELL; IMMUNOLOGY; IMMUNOTHERAPY; NEOPLASM; PATHOLOGY;

A549 CELLS; ANTIGENS, NEOPLASM; DENDRITIC CELLS; HUMANS; HYDROSTATIC PRESSURE; IMMUNOTHERAPY; NEOPLASMS;

EID: 85019120416     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2017.05.005     Document Type: Article

References (29)

1. Aertsen, A., Meersman, F., Hendrickx, M.E., Vogel, R.F., Michiels, C.W., Biotechnology under high pressure: applications and implications. Trends Biotechnol. 27:7 (2009), 434–441.
2. Rastogi, N.K., Raghavarao, K.S., Balasubramaniam, V.M., Niranjan, K., Knorr, D., Opportunities and challenges in high pressure processing of foods. Crit. Rev. Food Sci. Nutr. 47:1 (2007), 69–112.
3. Diehl, P., Schauwecker, J., Mittelmeier, W., Schmitt, M., High hydrostatic pressure, a novel approach in orthopedic surgical oncology to disinfect bone, tendons and cartilage. Anticancer Res. 28:6B (2008), 3877–3883.
4. Diehl, P., Schmitt, M., Blumelhuber, G., Frey, B., Van Laak, S., Fischer, S., Muehlenweg, B., Meyer-Pittroff, R., Gollwitzer, H., Mittelmeier, W., Induction of tumor cell death by high hydrostatic pressure as a novel supporting technique in orthopedic surgery. Oncol. Rep. 10:6 (2003), 1851–1855.
5. Helmstein, K., Treatment of bladder carcinoma by a hydrostatic pressure technique. Report on 43 cases. Br. J. Urol. 44:4 (1972), 434–450.
6. Richert, L., Or, A., Shinitzky, M., Promotion of tumor antigenicity in EL-4 leukemia cells by hydrostatic pressure. Cancer Immunol. Immunother. CII 22:2 (1986), 119–124.
7. Korn, A., Frey, B., Sheriff, A., Gaipl, U.S., Franz, S., Meyer-Pittroff, R., Bluemelhuberh, G., Herrmann, M., High hydrostatic pressure inactivated human tumour cells preserve their immunogenicity. Cell. Mol. Biol. 50:4 (2004), 469–477.
8. Weiss, E.M., Meister, S., Janko, C., Ebel, N., Schlucker, E., Meyer-Pittroff, R., Fietkau, R., Herrmann, M., Gaipl, U.S., Frey, B., High hydrostatic pressure treatment generates inactivated mammalian tumor cells with immunogeneic features. J. Immunotoxicol. 7:3 (2010), 194–204.
9. Eisenthal, A., Ramakrishna, V., Skornick, Y., Shinitzky, M., Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking. Cancer Immunol. Immunother. CII 36:5 (1993), 300–306.
10. Fucikova, J., Moserova, I., Truxova, I., Hermanova, I., Vancurova, I., Partlova, S., Fialova, A., Sojka, L., Cartron, P.F., Houska, M., Rob, L., Bartunkova, J., Spisek, R., High hydrostatic pressure induces immunogenic cell death in human tumor cells. J. Int. Cancer 135:5 (2014), 1165–1177.
11. Krysko, D.V., Garg, A.D., Kaczmarek, A., Krysko, O., Agostinis, P., Vandenabeele, P., Immunogenic cell death and DAMPs in cancer therapy. Nat. Rev. Cancer 12:12 (2012), 860–875.
12. Kroemer, G., Galluzzi, L., Kepp, O., Zitvogel, L., Immunogenic cell death in cancer therapy. Annu. Rev. Immunol. 31 (2013), 51–72.
13. Kepp, O., Galluzzi, L., Martins, I., Schlemmer, F., Adjemian, S., Michaud, M., Sukkurwala, A.Q., Menger, L., Zitvogel, L., Kroemer, G., Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy. Cancer Metastasis Rev. 30:1 (2011), 61–69.
14. Mikyskova, R., Stepanek, I., Indrova, M., Bieblova, J., Simova, J., Truxova, I., Moserova, I., Fucikova, J., Bartunkova, J., Spisek, R., Reinis, M., Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy. Int. J. Oncol. 48:3 (2016), 953–964.
15. Adkins, I., Fucikova, J., Garg, A.D., Agostinis, P., Spisek, R., Physical modalities inducing immunogenic tumor cell death for cancer immunotherapy. Oncoimmunology, 3(12), 2014, e968434.
16. Frey, B., Janko, C., Ebel, N., Meister, S., Schlucker, E., Meyer-Pittroff, R., Fietkau, R., Herrmann, M., Gaipl, U.S., Cells under pressure—treatment of eukaryotic cells with high hydrostatic pressure, from physiologic aspects to pressure induced cell death. Curr. Med. Chem. 15:23 (2008), 2329–2336.
17. Mentre, P., Hamraoui, L., Hui Bon Hoa, G., Debey, P., Pressure-sensitivity of endoplasmic reticulum membrane and nucleolus as revealed by electron microscopy. Cell. Mol. Biol. 45:3 (1999), 353–362.
18. Lammi, M.J., Elo, M.A., Sironen, R.K., Karjalainen, H.M., Kaarniranta, K., Helminen, H.J., Hydrostatic pressure-induced changes in cellular protein synthesis. Biorheology 41:3–4 (2004), 309–313.
19. Elo, M.A., Karjalainen, H.M., Sironen, R.K., Valmu, L., Redpath, N.T., Browne, G.J., Kalkkinen, N., Helminen, H.J., Lammi, M.J., High hydrostatic pressure inhibits the biosynthesis of eukaryotic elongation factor-2. J. Cell. Biochem. 94:3 (2005), 497–507.
20. Boonyaratanakornkit, B.B., Park, C.B., Clark, D.S., Pressure effects on intra- and intermolecular interactions within proteins. Biochim. Biophys. Acta 1595:1–2 (2002), 235–249.
21. Macgregor, R.B. Jr., Effect of hydrostatic pressure on nucleic acids. Biopolymers 48:4 (1998), 253–263.
22. Hradilova, N., Sadilkova, L., Palata, O., Mysikova, D., Mrazkova, H., Lischke, R., Spisek, R., Adkins, I., Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy. PLoS One, 12(2), 2017, e0171539.
23. Shi, H., Cao, T., Connolly, J.E., Monnet, L., Bennett, L., Chapel, S., Bagnis, C., Mannoni, P., Davoust, J., Palucka, A.K., Banchereau, J., Hyperthermia enhances CTL cross-priming. J. Immunol. 176:4 (2006), 2134–2141.
24. Feng, H., Zeng, Y., Graner, M.W., Katsanis, E., Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells. Blood 100:12 (2002), 4108–4115.
25. Takahashi, T., Mitsuhashi, N., Sakurai, H., Niibe, H., Modifications of tumor-associated antigen expression on human lung cancer cells by hyperthermia and cytokine. Anticancer Res. 15:6B (1995), 2601–2606.
26. Wong, J.Y., Mivechi, N.F., Paxton, R.J., Williams, L.E., Beatty, B.G., Beatty, J.D., Shively, J.E., The effects of hyperthermia on tumor carcinoembryonic antigen expression. Int. J. Radiat. Oncol. Biol. Phys. 17:4 (1989), 803–808.
27. Morimoto, R.I., Cells in stress: transcriptional activation of heat shock genes. Science 259:5100 (1993), 1409–1410.
28. Melcher, A., Todryk, S., Hardwick, N., Ford, M., Jacobson, M., Vile, R.G., Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat. Med. 4:5 (1998), 581–587.
29. Suto, R., Srivastava, P.K., A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides. Science 269:5230 (1995), 1585–1588.